News
- Author:
- Dan Watson
Publish date: September 22, 2017
Liver function should be monitored at baseline and during treatment for safe dosing.
News
- Author:
- Dan Watson
Publish date: September 21, 2017
The FDA says the benefits of combining MAT drugs with CNS depressants outweigh the risks.
News
- Author:
- Dan Watson
Publish date: September 14, 2017
Children’s mental health problems, poor peer relationships predicted a poorer quality of life for their parents decades later.
News
- Author:
- Dan Watson
Publish date: September 12, 2017
Ten-year overall survival was 86.3% in the sentinel lymph node dissection group, compared with 83.6% in the axillary lymph node dissection group, m...
News
- Author:
- Dan Watson
Publish date: September 11, 2017
Risk of adverse effects, including death, is higher.
News
- Author:
- Dan Watson
Publish date: August 30, 2017
This is the first regulatory approval for tivozanib, which was rejected by the FDA in 2013 for the treatment of RCC.
News
- Author:
- Dan Watson
Publish date: August 18, 2017
The supplemental New Drug Application is based on results from the CABOSUN trial.
News
- Author:
- Dan Watson
Publish date: August 18, 2017
But impairment does not necessarily predict a road test failure.
News
- Author:
- Dan Watson
Publish date: August 15, 2017
New research suggests it is possible to develop a point-of-care test for patients with urinary tract infections.
News
- Author:
- Dan Watson
Publish date: August 3, 2017
The first case of sustained HIV control in a child enrolled in a randomized trial of antiretroviral therapy interruption after treatment early in i...
News
- Author:
- Dan Watson
Publish date: August 2, 2017
Approval of the long-acting injectable form of aripiprazole is based on a 52-week withdrawal trial in adults.
News
- Author:
- Dan Watson
Publish date: July 31, 2017
The trial recently enrolled its first patient.
News
- Author:
- Dan Watson
Publish date: July 28, 2017
Perampanel (Fycompa) has been approved for monotherapy treatment of partial-onset seizures in patients aged 12 years or older.
News
- Author:
- Dan Watson
Publish date: July 21, 2017
The new formulation is the first self-injectable subcutaneous treatment available for patients with SLE.
News
- Author:
- Dan Watson
Publish date: July 11, 2017
New way to test for certain cancers shows promise.
